These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38025187)

  • 21. Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.
    Wu YL; Cheng Y; Zhou X; Lee KH; Nakagawa K; Niho S; Tsuji F; Linke R; Rosell R; Corral J; Migliorino MR; Pluzanski A; Sbar EI; Wang T; White JL; Nadanaciva S; Sandin R; Mok TS
    Lancet Oncol; 2017 Nov; 18(11):1454-1466. PubMed ID: 28958502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatoprotective effect of Baicalin against thioacetamide-induced cirrhosis in rats: Targeting NOX4/NF-κB/NLRP3 inflammasome signaling pathways.
    Zaghloul RA; Zaghloul AM; El-Kashef DH
    Life Sci; 2022 Apr; 295():120410. PubMed ID: 35182557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beneficial influence of rhubarb on 5-fluorouracil-induced ileal mucositis and the combined role of aquaporin-4, tumour necrosis factor-α, nuclear factor-kappa B & matrix metalloproteinase-9 in rat model: histological study.
    Kamar SS; Baky MH; Omar AI
    Anat Cell Biol; 2020 Jun; 53(2):228-239. PubMed ID: 32647090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of dacomitinib on reducing cell necrosis and enhancing cell apoptosis in C6 glioma rat model by MRI.
    Chen WS; Hong L; Wang F; Li JJ
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30782784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways.
    El-Ela SRA; Zaghloul RA; Eissa LA
    Nutrition; 2022 Oct; 102():111732. PubMed ID: 35816809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the potential effect of dacomitinib, an EGFR tyrosine kinase inhibitor, on ECG parameters in patients with advanced non-small cell lung cancer.
    Tan W; Giri N; Quinn S; Wilner K; Parivar K
    Invest New Drugs; 2020 Jun; 38(3):874-884. PubMed ID: 31858327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of local bee honey on dihydrofolate reductase enzyme inhibitor-induced mucositis: A histological study on albino wistar rats.
    Khanal L; Yadav P; Baral P; Shah R; Rauniar GP
    Indian J Dent Res; 2019; 30(5):708-715. PubMed ID: 31854361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baicalin ameliorates APEC-induced intestinal injury in chicks by inhibiting the PI3K/AKT-mediated NF-κB signaling pathway.
    Cheng X; Cao Z; Luo J; Hu R; Cao H; Guo X; Xing C; Yang F; Zhuang Y; Hu G
    Poult Sci; 2022 Jan; 101(1):101572. PubMed ID: 34844111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.
    Oh DY; Lee KW; Cho JY; Kang WK; Im SA; Kim JW; Bang YJ
    Gastric Cancer; 2016 Oct; 19(4):1095-1103. PubMed ID: 26581547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib.
    Kobayashi Y; Fujino T; Nishino M; Koga T; Chiba M; Sesumi Y; Ohara S; Shimoji M; Tomizawa K; Takemoto T; Mitsudomi T
    J Thorac Oncol; 2018 May; 13(5):727-731. PubMed ID: 29410323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats.
    Tang Y; Wu Y; Huang Z; Dong W; Deng Y; Wang F; Li M; Yuan J
    Nutrition; 2017 Jan; 33():96-104. PubMed ID: 27427511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the antitumor activity of dacomitinib in models of human bladder cancer.
    Grivas PD; Day KC; Karatsinides A; Paul A; Shakir N; Owainati I; Liebert M; Kunju LP; Thomas D; Hussain M; Day ML
    Mol Med; 2013 Nov; 19(1):367-76. PubMed ID: 24166682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhubarb extract partially improves mucosal integrity in chemotherapy-induced intestinal mucositis.
    Bajic JE; Eden GL; Lampton LS; Cheah KY; Lymn KA; Pei JV; Yool AJ; Howarth GS
    World J Gastroenterol; 2016 Oct; 22(37):8322-8333. PubMed ID: 27729739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect and potential mechanisms of Wei-Chang-An pill on high-dose 5-fluorouracil-induced intestinal mucositis in mice.
    Chen Y; Zheng H; Zhang J; Wang L; Jin Z; Gao W
    J Ethnopharmacol; 2016 Aug; 190():200-11. PubMed ID: 27240747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization and Accumulation Studies of Dacomitinib in Rat Intestines and Skin by Immunohistochemistry.
    Yamamoto Y; Saita T; Oka A; Kataoka H; Shin M
    Acta Histochem Cytochem; 2019 Dec; 52(6):101-106. PubMed ID: 32001948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Inhibiting TLR4/JNK/ERK/NF-
    Long Y; Xiang Y; Liu S; Zhang Y; Wan J; Yang Q; Cui M; Ci Z; Li N; Peng W
    Mediators Inflamm; 2020; 2020():8414062. PubMed ID: 33223957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050).
    Cheng Y; Mok TS; Zhou X; Lu S; Zhou Q; Zhou J; Du Y; Yu P; Liu X; Hu C; Lu Y; Zhang Y; Lee KH; Nakagawa K; Linke R; Wong CH; Tang Y; Zhu F; Wilner KD; Wu YL
    Lung Cancer; 2021 Apr; 154():176-185. PubMed ID: 33721611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro.
    Zhu L; Lopez S; Bellone S; Black J; Cocco E; Zigras T; Predolini F; Bonazzoli E; Bussi B; Stuhmer Z; Schwab CL; English DP; Ratner E; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Santin AD
    Tumour Biol; 2015 Jul; 36(7):5505-13. PubMed ID: 25669172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
    Nishio M; Kato T; Niho S; Yamamoto N; Takahashi T; Nogami N; Kaneda H; Fujita Y; Wilner K; Yoshida M; Isozaki M; Wada S; Tsuji F; Nakagawa K
    Cancer Sci; 2020 May; 111(5):1724-1738. PubMed ID: 32159882
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Zheng X; Mai L; Xu Y; Wu M; Chen L; Chen B; Su Z; Chen J; Chen H; Lai Z; Xie Y
    Front Pharmacol; 2023; 14():1136076. PubMed ID: 36895947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.